Skip to main content
. 2022 Apr 28;17(4):e0267117. doi: 10.1371/journal.pone.0267117

Fig 2. The pro-carcinogenic role of SNX16 in HCC.

Fig 2

(A) Differential expression of SNX16 in HCC based on TCGA data. (B) Differential expression of SNX16 in paraneoplastic and HCC tissues based on TCGA data. (C) Differential expression of SNX16 in dataset GSE25097. (D) Analysis of overall survival of SNX16 in HCC patients. (E) Correlation of SNX16 expression with TNM stage. (F) Correlation of SNX16 expression with invasion depth.